Specifically, the 3-year OS rate with Multikine plus cyclophosphamide, indomethacin, and zinc-multivitamins (CIZ) and SOC was 72.4% vs 78.8% with Multikine (no CIZ) and SOC, and 67.5% with SOC alone. The 5-year OS rates in these groups were 62.7% vs 55.5% vs 48.6%, respectively. The primary survival comparison was predefined to examine only the first and last groups.
C in CiZ is mustard gas Cisplatin
... granted that is not exactly chemo-therapy in this form, but it is still remarkably suggestive that MK doesn't like to work with Cisplatin as much as it likes to work alone